Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 5
2006 2
2007 2
2008 5
2009 7
2010 2
2011 2
2012 3
2013 12
2014 13
2015 13
2016 3
2017 6
2018 16
2019 12
2020 9
2021 8
2022 10
2023 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Keenan TDL, Oden NL, Agrón E, Clemons TE, Henning A, Wong WT, Chew EY. Keenan TDL, et al. Among authors: clemons te. Ophthalmol Retina. 2022 Apr;6(4):334-335. doi: 10.1016/j.oret.2021.12.002. Ophthalmol Retina. 2022. PMID: 35393078 No abstract available.
Reply.
Le JT, Peprah D, Agrón E, Keenan TDL, Clemons TE, Chew EY. Le JT, et al. Among authors: clemons te. Ophthalmology. 2022 Jun;129(6):e67-e68. doi: 10.1016/j.ophtha.2022.02.014. Epub 2022 Apr 1. Ophthalmology. 2022. PMID: 35379480 No abstract available.
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Chew EY, et al. Among authors: clemons te. JAMA Ophthalmol. 2022 Jul 1;140(7):692-698. doi: 10.1001/jamaophthalmol.2022.1640. JAMA Ophthalmol. 2022. PMID: 35653117 Free PMC article. Clinical Trial.
Reply.
van Asten F, Chiu CY, Agrón E, Clemons TE, Ratnapriya R, Swaroop A, Klein ML, Fan R, Chew EY. van Asten F, et al. Among authors: clemons te. Ophthalmology. 2020 Mar;127(3):e19-e20. doi: 10.1016/j.ophtha.2019.10.033. Ophthalmology. 2020. PMID: 32087877 Free PMC article. No abstract available.
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY; AREDS2 Research Group. Keenan TD, et al. Among authors: clemons te. Ophthalmology. 2018 Dec;125(12):1913-1928. doi: 10.1016/j.ophtha.2018.05.028. Epub 2018 Jul 27. Ophthalmology. 2018. PMID: 30060980 Free PMC article. Clinical Trial.
Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10.
Chew EY, Peto T, Clemons TE, Sallo FB, Pauleikhoff D, Leung I, Jaffe GJ, Heeren TFC, Egan CA, Charbel Issa P, Balaskas K, Holz FG, Gaudric A, Bird AC, Friedlander M. Chew EY, et al. Among authors: clemons te. Ophthalmol Sci. 2022 Dec 8;3(2):100261. doi: 10.1016/j.xops.2022.100261. eCollection 2023 Jun. Ophthalmol Sci. 2022. PMID: 36846105 Free PMC article.
Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 30.
Agrón E, Domalpally A, Cukras CA, Clemons TE, Chen Q, Lu Z, Chew EY, Keenan TDL; AREDS and AREDS2 Research Groups. Agrón E, et al. Among authors: clemons te. Ophthalmology. 2022 Oct;129(10):1107-1119. doi: 10.1016/j.ophtha.2022.05.021. Epub 2022 May 31. Ophthalmology. 2022. PMID: 35660417 Free PMC article.
113 results